Cargando…
Quantification of myocardium at risk in ST- elevation myocardial infarction: a comparison of contrast-enhanced steady-state free precession cine cardiovascular magnetic resonance with coronary angiographic jeopardy scores
BACKGROUND: Clinical outcome following acute myocardial infarction is predicted by final infarct size evaluated in relation to left ventricular myocardium at risk (MaR). Contrast-enhanced steady-state free precession (CE-SSFP) cardiovascular magnetic resonance imaging (CMR) is not widely used for as...
Autores principales: | De Palma, Rodney, Sörensson, Peder, Verouhis, Dinos, Pernow, John, Saleh, Nawzad |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5530997/ https://www.ncbi.nlm.nih.gov/pubmed/28750637 http://dx.doi.org/10.1186/s12968-017-0359-1 |
Ejemplares similares
-
Assessment of myocardium at risk with contrast enhanced steady-state free precession cine cardiovascular magnetic resonance compared to single-photon emission computed tomography
por: Sörensson, Peder, et al.
Publicado: (2010) -
Myocardium at risk by magnetic resonance imaging: head-to-head comparison of T2-weighted imaging and contrast-enhanced steady-state free precession
por: Ubachs, Joey F.A., et al.
Publicado: (2012) -
Myocardium at risk quantified by contrast enhanced steady-state free precession does not differ in extent or severity when comparing patients with ST-elevation myocardial infarction treated with standard reperfusion or postconditioning
por: Sörensson, Peder, et al.
Publicado: (2015) -
Myocardium at risk by magnetic resonance imaging: head-to-head comparison of T2-weighted imaging and early gadolinium enhanced steady state free precession
por: Ubachs, Joey F, et al.
Publicado: (2012) -
Erythrocytes from patients with ST-elevation myocardial infarction induce cardioprotection through the purinergic P2Y(13) receptor and nitric oxide signaling
por: Jiao, Tong, et al.
Publicado: (2022)